T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

about

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Item

http://www.wikidata.org/entity/Q38758212

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

T- and B-cell responses to mul ...... C virus in non-human primates.

@en

type

Item

label

T- and B-cell responses to mul ...... C virus in non-human primates.

@en

prefLabel

T- and B-cell responses to mul ...... C virus in non-human primates.

@en

P1476

T- and B-cell responses to mul ...... C virus in non-human primates

@en

P2093

B E Verstrepen

http://www.w3.org/2001/XMLSchema#string

C S Rollier

http://www.w3.org/2001/XMLSchema#string

E J Verschoor

http://www.w3.org/2001/XMLSchema#string

G Inchauspe

http://www.w3.org/2001/XMLSchema#string

G Paranhos-Baccala

http://www.w3.org/2001/XMLSchema#string

J A R Drexhage

http://www.w3.org/2001/XMLSchema#string

L Arribillaga

http://www.w3.org/2001/XMLSchema#string

P Liljeström

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?

Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

Vaccination of chimpanzees against infection by the hepatitis C virus

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.

P2888

gt.2016.55

P304

753-759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2016.55

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27416077

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease